Metastatic Melanoma (mM) | 623 patients |
62% male, 38% female | |
Median age, 53 years, | |
Range, 19–84 years | |
Metastatic Renal Cell Cancer (mRCC) | 919 patients |
72% male, 28% female | |
Median age, 57 years, | |
Range, 18–84 years | |
7 patients had both mM and mRCC – counted in each subset | |
Data retrospectively accrued | 426 patients |
Data prospectively accrued | 1109 patients (72%) |
Median follow-up | 3.5+ years, range 1–8+ years |